Melinda VanRoey
- Oncology top 5%
- Molecular Biology top 10%
- Immunology top 5%
- Genetics top 5%
- Biotechnology top 5%
- Co-authors
- Karin JoossThomas C. HardingGuang Huan TuBetty LiJianmin FangAndrew D. SimmonsJingjing QianBo Luan
- Topics
- CAR-T cell therapy research (15 papers)Immunotherapy and Immune Responses (11 papers)Virus-based gene therapy research (9 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Melinda VanRoey
21 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 80
- Oncology 768
- Molecular Biology 707
- Immunology 552
- Genetics 412
- Biotechnology 124
Countries citing papers authored by Melinda VanRoey
This map shows the geographic impact of Melinda VanRoey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melinda VanRoey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melinda VanRoey more than expected).
Fields of papers citing papers by Melinda VanRoey
This network shows the impact of papers produced by Melinda VanRoey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melinda VanRoey. The network helps show where Melinda VanRoey may publish in the future.
Co-authorship network of co-authors of Melinda VanRoey
This figure shows the co-authorship network connecting the top 25 collaborators of Melinda VanRoey. A scholar is included among the top collaborators of Melinda VanRoey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melinda VanRoey. Melinda VanRoey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 153 | |
| 2 | 16 | |
| 3 | 34 | |
| 4 | 47 | |
| 5 | 15 | |
| 6 | 21 | |
| 7 | 14 | |
| 8 | 83 | |
| 9 | 84 | |
| 10 | 49 | |
| 11 | 33 | |
| 12 | 36 | |
| 13 | 26 | |
| 14 | 33 | |
| 15 | 306 | |
| 16 | 19 | |
| 17 | 202 | |
| 18 | 22 | |
| 19 | 34 | |
| 20 | 25 |
About Melinda VanRoey
Melinda VanRoey is a scholar working on Oncology, Immunology and Genetics, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (15 papers), Immunotherapy and Immune Responses (11 papers) and Virus-based gene therapy research (9 papers). The work is most often cited by research in Oncology (768 citations), Immunology (552 citations) and Genetics (412 citations). Melinda VanRoey has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Karin Jooss, Thomas C. Harding, Guang Huan Tu, Betty Li, Jianmin Fang, Andrew D. Simmons, Jingjing Qian, Bo Luan, Alshad S. Lalani and Kathryn Koprivnikar. Their work appears in journals such as Nature Biotechnology, Cancer Research and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.